HMGB1 and Cerebral ischemia: Inhibition of HMGB1 remote ischemic preconditioning and post-ischemic treatment reduced plasma HMGB1 levels and enhanced its neuroprotective effects against cerebral ischemia–reperfusion injury by inhibiting autophagic processes [173].